Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Assembly Biosciences (ASMB) Accumulated Depreciation & Amortization (2016 - 2023)

Historic Accumulated Depreciation & Amortization for Assembly Biosciences (ASMB) over the last 9 years, with Q4 2023 value amounting to $210000.0.

  • Assembly Biosciences' Accumulated Depreciation & Amortization fell 8755.19% to $210000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $210000.0, marking a year-over-year decrease of 8755.19%. This contributed to the annual value of $210000.0 for FY2023, which is 8755.19% down from last year.
  • Latest data reveals that Assembly Biosciences reported Accumulated Depreciation & Amortization of $210000.0 as of Q4 2023, which was down 8755.19% from $1.7 million recorded in Q4 2022.
  • Assembly Biosciences' 5-year Accumulated Depreciation & Amortization high stood at $1.8 million for Q4 2020, and its period low was $135000.0 during Q1 2019.
  • Its 5-year average for Accumulated Depreciation & Amortization is $1.1 million, with a median of $1.2 million in 2019.
  • Per our database at Business Quant, Assembly Biosciences' Accumulated Depreciation & Amortization soared by 85481.48% in 2020 and then plummeted by 8755.19% in 2023.
  • Assembly Biosciences' Accumulated Depreciation & Amortization (Quarter) stood at $1.2 million in 2019, then surged by 53.0% to $1.8 million in 2020, then plummeted by 34.26% to $1.2 million in 2021, then soared by 39.77% to $1.7 million in 2022, then crashed by 87.55% to $210000.0 in 2023.
  • Its Accumulated Depreciation & Amortization stands at $210000.0 for Q4 2023, versus $1.7 million for Q4 2022 and $1.2 million for Q4 2021.